How can we improve access and affordability for safe, quality, and effective medicines and treatments?
Atlantic staff will join experts to discuss the importance of generics and biosimilars and how the industry is adapting to challenges such as rising drug prices, patent reform, and emerging health threats while continuing to provide affordable, high-quality medicines.